- Home
- AMWL vs KOD Comparison
AMWL vs KOD Comparison
Compare AMWL & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWL
- KOD
- Stock Information
- Founded
- AMWL 2006
- KOD 2009
- Country
- AMWL United States
- KOD United States
- Employees
- AMWL N/A
- KOD N/A
- Industry
- AMWL Retail: Computer Software & Peripheral Equipment
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMWL Technology
- KOD Health Care
- Exchange
- AMWL Nasdaq
- KOD Nasdaq
- Market Cap
- AMWL 121.9M
- KOD 115.0M
- IPO Year
- AMWL 2020
- KOD 2018
- Fundamental
- Price
- AMWL $6.88
- KOD $3.77
- Analyst Decision
- AMWL Hold
- KOD Hold
- Analyst Count
- AMWL 6
- KOD 3
- Target Price
- AMWL $10.00
- KOD $9.00
- AVG Volume (30 Days)
- AMWL 58.2K
- KOD 463.2K
- Earning Date
- AMWL 05-01-2025
- KOD 05-19-2025
- Dividend Yield
- AMWL N/A
- KOD N/A
- EPS Growth
- AMWL N/A
- KOD N/A
- EPS
- AMWL N/A
- KOD N/A
- Revenue
- AMWL $261,675,000.00
- KOD N/A
- Revenue This Year
- AMWL $2.28
- KOD N/A
- Revenue Next Year
- AMWL $10.06
- KOD N/A
- P/E Ratio
- AMWL N/A
- KOD N/A
- Revenue Growth
- AMWL 2.79
- KOD N/A
- 52 Week Low
- AMWL $5.00
- KOD $1.92
- 52 Week High
- AMWL $12.95
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- AMWL 44.58
- KOD 50.83
- Support Level
- AMWL $6.42
- KOD $3.66
- Resistance Level
- AMWL $7.15
- KOD $4.20
- Average True Range (ATR)
- AMWL 0.61
- KOD 0.49
- MACD
- AMWL 0.00
- KOD 0.00
- Stochastic Oscillator
- AMWL 36.28
- KOD 25.14
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.